Literature DB >> 3913501

Age and the endocrine system.

R H Noth, E L Mazzaferri.   

Abstract

The pattern of age-induced changes in each endocrine system is unique. Both hormone levels and target organ responsivity are altered in the aging endocrine-cardiovascular system. Serum levels of vasopressor hormones both increase (norepinephrine) and decrease (renin, aldosterone). Target organ responses to beta-adrenergic stimulation in the heart and probably also in vascular smooth muscle decrease due to postreceptor changes. These effects contribute to the clinical problems of hypertension and orthostatic hypotension which characterize the elderly. Aging produces mild carbohydrate intolerance and a minimal increase in fasting serum glucose in healthy, nonobese individuals, primarily due to decreasing postreceptor responsiveness to insulin. Aging decreases the metabolism of thyroxine, including its conversion to triiodothyronine, but clinically significant alterations of thyroid hormone levels do not occur. Changes in the end-organ response to thyroid hormones, however, significantly alter the clinical presentation of thyroid diseases. Aging shifts the serum vasopressin-serum osmolality relationship toward higher serum vasopressin levels probably due to altered baroreceptor input, probably contributing to the tendency toward hyponatremia in the elderly. Aging slows the metabolism of cortisol, but glucocorticoid levels in the human are essentially unaltered by age. However, recent data indicate that delta-5 adrenal steroids decrease markedly in both men and women. Nodules in the anterior pituitary, the thyroid, and the adrenal increase in frequency with aging. Finally, the reproductive system is primarily altered by endocrine cell death, by unknown mechanisms, resulting in decreased estrogen and testosterone levels in women and men. This most obvious age-related endocrine change turns out to be incompletely understood and is not representative of most age-related endocrine changes. Despite characterization of these many age-related alterations in endocrine systems, therapeutic issues often remain unexplored, and more data are needed in many areas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913501

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  9 in total

Review 1.  Chlorinated persistent organic pollutants, obesity, and type 2 diabetes.

Authors:  Duk-Hee Lee; Miquel Porta; David R Jacobs; Laura N Vandenberg
Journal:  Endocr Rev       Date:  2014-01-31       Impact factor: 19.871

2.  Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly.

Authors:  W Musch; G Decaux
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Toxicoanthropology: Phthalate exposure in relation to market access in a remote forager-horticulturalist population.

Authors:  Marissa Sobolewski; Bernard Weiss; Melanie Martin; Michael Gurven; Emily Barrett
Journal:  Int J Hyg Environ Health       Date:  2017-03-27       Impact factor: 5.840

Review 4.  Effects of aging on muscle fibre type and size.

Authors:  Michael R Deschenes
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study.

Authors:  Duk-Hee Lee; P Monica Lind; David R Jacobs; Samira Salihovic; Bert van Bavel; Lars Lind
Journal:  Diabetes Care       Date:  2011-06-23       Impact factor: 19.112

6.  Aging, resistance training, and diabetes prevention.

Authors:  Kyle D Flack; Kevin P Davy; Matthew W Hulver; Richard A Winett; Madlyn I Frisard; Brenda M Davy
Journal:  J Aging Res       Date:  2010-12-15

7.  Changes in IL-16 Expression in the Ovary during Aging and Its Potential Consequences to Ovarian Pathology.

Authors:  Jessica Ramirez; Pincas Bitterman; Sanjib Basu; Animesh Barua
Journal:  J Immunol Res       Date:  2022-04-26       Impact factor: 4.493

8.  Testosterone Pathway Genetic Polymorphisms in Relation to Primary Open-Angle Glaucoma: An Analysis in Two Large Datasets.

Authors:  Jessica N Cooke Bailey; Puya Gharahkhani; Jae H Kang; Mariusz Butkiewicz; David A Sullivan; Robert N Weinreb; Hugues Aschard; R Rand Allingham; Allison Ashley-Koch; Richard K Lee; Sayoko E Moroi; Murray H Brilliant; Gadi Wollstein; Joel S Schuman; John H Fingert; Donald L Budenz; Tony Realini; Terry Gaasterland; William K Scott; Kuldev Singh; Arthur J Sit; Robert P Igo; Yeunjoo E Song; Lisa Hark; Robert Ritch; Douglas J Rhee; Douglas Vollrath; Donald J Zack; Felipe Medeiros; Thasarat S Vajaranant; Daniel I Chasman; William G Christen; Margaret A Pericak-Vance; Yutao Liu; Peter Kraft; Julia E Richards; Bernard A Rosner; Michael A Hauser; Jamie E Craig; Kathryn P Burdon; Alex W Hewitt; David A Mackey; Jonathan L Haines; Stuart MacGregor; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

9.  Persistent Organochlorine Pollutants in Plasma, Blood Pressure, and Hypertension in a Longitudinal Study.

Authors:  Carolina Donat-Vargas; Agneta Åkesson; Andreas Tornevi; Maria Wennberg; Johan Sommar; Hannu Kiviranta; Panu Rantakokko; Ingvar A Bergdahl
Journal:  Hypertension       Date:  2018-04-30       Impact factor: 10.190

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.